A research team from the University of Michigan analyzed data from the US papillomavirus (HPV) vaccination campaign and found that between 2010 and 2018, less than one-third of adolescents received full coverage. Because the virus also causes oral cancer (which has been steadily increasing in recent years, and the incidence rate in men is three times that of women), many young men are dying of preventable cancer.
By analyzing the vaccination rate Human papilloma virus (HPV), an American research team found that only 16% boys Between 18 and 21 years old, he received First dose of vaccine, While only 42% of girls.Human papillomavirus (HPV) is often associated with Cervical cancer, But it can also be responsible for Penile cancer He was born Anal cancerAnd is causing Oropharyngeal tumors, This is a cancer that has become more and more common in recent years.As mentioned before By the Italian Association for Research on Cancer (AIRC), Oral cancer affects men Triple percentage More than women, accounting for 10% of women Malignant tumor Male (4% female). AIRC pointed out ItalyApproximately 4,500 oral cancer cases are diagnosed each year, and 3,000 deaths are recorded.
A U.S. research team led by scientists from the Department of Otolaryngology-Head and Neck Surgery at the University of Michigan, in collaboration with them, determined that the human papillomavirus (HPV) vaccination rate is much lower than that of women. Diseases, Obstetrics and Gynecology and Surgery. Scientists coordinated by Professor Michelle M. Chen came to their conclusions after analyzing data on HPV vaccination campaigns between 2010 and 2018. According to the instructions of the US health authorities, the HPV vaccine is recommended to be used in young people under the age of 26, taking 2 doses at the age of 11-12 and a booster at the age of 13-26.After crossing all the data, it was found that less than one-third of the children received Full coverage Vaccine; Considering the rapid development of oral cancer and its lethality, the lack of this management method among young people makes it easy for many victims to prevent.
although HPV vaccine The drug was approved in the United States in 2006 and can be used for women with cervical cancer. It will also be used for men three years later. It will not be included in the prevention of pharyngeal cancer until 2020, and this number is still increasing. Michelle Chen, a head, neck and throat surgeon at the University of Michigan, said: “I think that not many people, whether they are providers or patients, realize that this vaccine is actually a vaccine to prevent cancer in men and women.” She added: “But HPV-related oropharyngeal cancer can affect anyone-and there is no effective screening method, which makes vaccination even more important.”
Thanks to the vaccination of young women, the statistics of cervical cancer have plummeted.in Australia, The vaccine is provided free of charge to Teenage studentsThis disease has almost been eradicated, and I believe it will be completely defeated soon. Therefore, the study authors recommend that boys and girls be vaccinated against HPV as much as possible in order to reach HPV as soon as possible.Herd immunity And stop the growth of oropharyngeal cancer in the details of the study”HPV vaccination among young Americans“Published in the scientific journal “JAMA-Research Letter”.